Page 105 - Micron News Today

In a recent study posted to the bioRxiv* preprint server, researchers in the United States described a blocking enzyme-linked immunosorbent assay (ELISA) to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exposure in animals.

In a recent study published in the journal mBio, researchers in the United States evaluated rat exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in New York City (NYC).

Filipino victims of sex slavery by Japanese forces during World War II have rejected a move for compensation, saying the money is useless at this age

The chipmaker cited several reasons for selecting the site including its proximity to higher education institutions, reliable access to power and water, and a strong military population...

While the COVID-19 public emergency may have ended, some health officials continue to emphasize the importance of prevention and preparedness.

Researchers model predictions of the COVID-19 pandemic trajectory under different variant and intervention scenarios.

A study published in JAMA Network Open explores the protective efficacy of previous exposure to omicron subvariants and booster vaccination against severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) omicron BA.5 infection.

The US Food and Drug Administrations committee of independent vaccine experts gathered Thursday to discuss the future of COVID-19 shots. The meeting seemed pri

Researchers from The University of Texas MD Anderson Cancer Center have developed fully human bispecific antibodies, as revealed in a recent study. These antibodies can bind to two distinct epitopes of the receptor binding domain (RBD) of the SARS-CoV-2 spike protein and have demonstrated the ability to neutralize various strains of the virus, including the Omicron variant.

Researchers compare viral kinetics of successive SARS-CoV-2 infections.